Notably, ZEB1 downregulation was associated to a more invasive phenotype in lung cancer [153], suggesting that ZEB1-induced EMT and ESRP1-mediated splicing of CD44 could contribute to initial transitions of the metastatic progression. The gene discussed is ZEB1; the disease is lung carcinoma.